Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FTVZ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,872
Award facts
- Contract value 100% obligated
- $11,871.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,871.86 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on July 22, 2025, for the supply of Zepbound 15 mg/0.5 mL pen injections. This firm fixed-price delivery order, which is set to be completed by July 23, 2025, represents a single shipment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $500 million through November 2026. The performance location for this delivery is listed as Conshohocken, Pennsylvania. Zepbound is a pharmaceutical treatment used in weight management, and this delivery order fulfills the Defense Logistics Agency's pharmaceutical supply requirements for military healthcare facilities.
DMS Pharmaceutical Group, based in Park Ridge, Illinois, has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts with the Defense Logistics Agency for a diverse portfolio of medications and medical supplies. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets without set-aside designations. Through its comprehensive Indefinite Delivery Contract vehicle, DMS Pharmaceutical Group provides prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites nationwide, supporting military medical operations and readiness requirements.
Quick answers
Who was awarded contract SPE2DB25FTVZ9?
SPE2DB25FTVZ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FTVZ9 worth?
The government has obligated $11,872 on SPE2DB25FTVZ9.
Is contract SPE2DB25FTVZ9 an order under another contract?
Yes. SPE2DB25FTVZ9 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTVZ9 competed?
The extent of competition for SPE2DB25FTVZ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award